Navigation Links
Columbus Center for Women’s Health Research is participating in an International Study for a New “Use-as-Needed” Treatment for Women with Sexual Dysfunction
Date:2/23/2013

Columbus, OH (PRWEB) February 23, 2013

Female Sexual Dysfunction affect women worldwide. Columbus Center for Women’s Health Research or CCWHR is participating in one of the largest clinical studies to ever explore a “use-as-needed” treatment, Tefina™, for women experiencing orgasmic disorder. The study, which will involve 240 patients in the U.S., Canada and Australia, will evaluate if there is an increase in the occurrence of orgasm over the treatment period, compared against baseline levels.

Recently there has been a lot of media coverage surrounding this study with references to Tefina as “female-viagra”. Tefina™ is a nasal gel containing bio-identical testosterone and is gently placed on the inside wall of the nose with an easy to use applicator 1-4 hours before sexual activity. The gel is designed to adhere to the nasal wall and not drip out, allowing the testosterone to be absorbed through the nasal lining within 10-15 minutes of application. Female Orgasmic Disorder, also known as Female Anorgasmia, is defined as the persistent or recurrent delay in or absence of orgasm. Although this condition is estimated to affect up to 1 in 5 women worldwide, there are no FDA approved treatments.

“Tefina™ is a potentially revolutionary treatment to restore women’s ability to obtain orgasm and sexual satisfaction” says Dr. Kingsberg, Primary Investigator of the study and Chief of Behavioral Medicine at UH MacDonald Women’s Hospital. “Low sexual satisfaction is linked to a lower sense of well-being as well as to tension in relationships. We are hopeful that this be a real help for patients who say ‘sex has become a chore.’

Participants must be aged 18 to 65 and be unable to be sexually satisfied after previously having had no problems. David J. Portman, MD is the PI for the local trial site at Columbus Center for Women’s Health Research. Dr. Portman founded the Columbus Center for Women's Health Research in 1997 and has conducted many clinical studies in hormone therapy, osteoporosis, contraception, endocrine and heart disease and other issues pertaining to OB/GYN. In addition, he is recognized as one of the country's leading experts in menopause and the treatment options available to women today. He lectures extensively across the country on this and related topics, and frequently consults on issues related to Women's Health. For more information on current studies, call 614-861-6707 or visit http://www.ccwhr.com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10457472.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hearing Health Solutions Now Makes Finding Hearing Aids in Columbus, OH Easier with Complimentary Hearing Screenings
2. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
3. Milford, Ohio: Periodontists of the Ohio Valley Center for Periodontics & Implants Now Bring a Modern Gum Surgery Alternative to their Local Gum Disease Patients
4. Mesothelioma Victims Center's Now Urges All US Navy Veterans Diagnosed With Mesothelioma Cancer To Call Them For Contacts For The Best Mesothelioma Law Firms
5. The MS Center of Atlanta Partners with Georgia Partnership for TeleHealth
6. Save the Date Durand Community Blood Drives at the American Legion with the Rock River Valley Blood Center
7. Delray Recovery Center Treats Steroid and Performance Enhancing Drug Abuse
8. Lung Cancer Asbestos Victims Center Now Strongly Encourages Lung Cancer Victims To Call Them If They Were Exposed To Asbestos In Their Workplace-Possible Compensation
9. Mesothelioma Victims Center Now Urges All Victims Of Mesothelioma To Call Them For The Names Of Most Skilled Mesothelioma Law Firms-Because They Get The Best Results
10. The Center for Wound Healing, Inc. Acquires Assets from Restorix Health
11. Personal Enhancement Center Runs Sandy Holiday Fundraiser
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
(Date:2/5/2016)... ... 05, 2016 , ... VeloReality President and co-founder ... LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the ... reduce the weight of the unit, they also enhance the rider's experience with ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official operators ... to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the ... Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of the nation’s ... weekend’s Big Game. Take the stress out of your party preparation – follow these ... at every stage of the game. , “The key to hosting a successful game-day ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... 2016 Global Immunology Market to 2022 ... long-term market growth Summary Immune-mediated inflammatory ... disorders that affect 5–7% of western populations. Although ... symptoms and key patient demographics, they are pathophysiologically ... and an inappropriate immune response. Generally, disease-modifying anti-rheumatic ...
Breaking Medicine Technology: